SAB Biotherapeutics SABS Q1 2026 earnings
Reported May 12, 2026 · Before market open
EPS-$0.35Miss by $0.15
Revenue estimate$125.0K
EPS estimate-$0.20
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$125.0K
EPS estimate-$0.29
Versus estimates
Revenue
Diluted EPS
Ask the moment SAB Biotherapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did SAB Biotherapeutics report Q1 2026 earnings?
- SAB Biotherapeutics (SABS) reported Q1 2026 earnings on May 12, 2026 before market open.
- What were SAB Biotherapeutics's Q1 2026 revenue and EPS?
- SAB Biotherapeutics reported eps of $-0.35 for Q1 2026.
- Did SAB Biotherapeutics beat estimates in Q1 2026?
- EPS missed the consensus estimate of $-0.20 by $0.15.
- How did SAB Biotherapeutics's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 37.5% from $-0.56.
- Where can I find SAB Biotherapeutics's Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001193125-26-218195) directly on SEC EDGAR. The filing index links above go to sec.gov.